PCN113 PHARMACOECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS 5-FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE FIRST LINE TREATMENT OF METASTASIS COLORECTAL CANCER IN TAIWAN

Oct 1, 2009, 00:00 AM
10.1016/S1098-3015(10)74364-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)74364-3/fulltext
Section Title :
Section Order : 290
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74364-3&doi=10.1016/S1098-3015(10)74364-3
HEOR Topics :
Tags :
Regions :